← Back to patent-cliff list
CAS 1154243-75-0
4-(4-bromophenoxy)-N-methylpicolinamide
Codes: SORF-014
Application context (from source-drug indications)
Thyroid cancerSorafenib TosylateHepatocellular carcinomaSorafenib TosylateRenal cell carcinomaSorafenib TosylateAggressive fibromatosisSorafenib TosylateLiver cancerSorafenib TosylateMyeloproliferative neoplasmSorafenib Tosylate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Sorafenib Tosylate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-bromo-1-chloro-2-(trifluoromethyl)benzene→1-(2,4-dimethoxybenzyl)urea→1-(4-chloro-3-(trifluoromethyl)phenyl)urea→4-(4-bromophenoxy)-N-methylpicolinamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.